Forecast: Pharmaceuticals in Dosage Market Size Value in Spain

Between 2013 and 2023, the pharmaceuticals in dosage market size value in Spain showed a general downward trend, starting from $49.134 billion in 2013 and decreasing to $40.114 billion in 2023. The series is expressed in Value. This period featured fluctuations with significant declines in some years, such as 2016 and 2017, and a few years of moderate recovery, such as 2018 and 2020. The year-on-year variation was -4.01% in 2023. The Compound Annual Growth Rate (CAGR) for the last five years leading up to 2023 was -0.84%.

Forecasts from 2024 onwards suggest a continuation of the declining trend, with the market expected to reach $31.983 billion by 2028. The forecast 5-year CAGR is -3.62%, translating to a forecast 5-year growth rate of -16.83%.

Future trends to watch for in the pharmaceuticals market in Spain include advancements in biotechnology, increasing investment in generic drugs, and the impact of healthcare policies and regulations on market dynamics. Additionally, the role of health technology and digital health solutions may become more prominent in the coming years.